The local lymph node assay: past, present and future

Contact Dermatitis - Tập 47 Số 6 - Trang 315-328 - 2002
Ian Kimber1, Rebecca J. Dearman2, David A. Basketter3, Cindy A. Ryan4, G. Frank Gerberick4
1Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, UK
2Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire,
3SEAC Toxicology Unit, Unilever Research, Colworth House, Sharnbrook, Bedfordshire, UK,
4Miami Valley Laboratories, Procter & Gamble Company, Cincinnati, Ohio, USA

Tóm tắt

The local lymph node assay (LLNA) was developed originally as a method for the identification of chemicals that have the potential to cause skin sensitization and allergic contact dermatitis. The assay is based on an understanding that the acquisition of contact sensitization is associated with, and dependent upon, the stimulation by chemical allergens of lymphocyte proliferative responses in skin‐draining lymph nodes. Those chemicals that provoke a defined level of lymph node cell (LNC) proliferation (a 3‐fold or greater increase compared with concurrent vehicle controls) are classified as skin sensitizers. Following its original inception and development, the LLNA was the subject of both national and international interlaboratory collaborative trials, and of very detailed comparisons with other test methods and with human skin sensitization data. The assay has now been validated fully as a stand‐alone test for the purposes of hazard identification. In recent years, there has been a growing interest also in the use of the LLNA to assess the potency of contact allergens and in risk assessment. There is reason to believe that the extent of skin sensitization achieved is associated with the vigour of LNC proliferation induced in draining nodes. Given this relationship, the relative potency of skin sensitizing chemicals is measured in the LLNA by derivation of an EC3 value, this being the concentration of chemical required to provoke a 3‐fold increase in the proliferation of LNC compared with controls. Experience to date indicates that relative potency as determined using this approach correlates closely with what is known of the activity of skin sensitizing chemicals in humans. In this article, we review the development, evaluation and validation of the LLNA for the purposes of hazard identification, and the more recent application of the method for evaluation of potency in the context of risk assessment. In addition, we consider what new applications and modifications are currently being investigated.

Từ khóa


Tài liệu tham khảo

Kimber I, 1996, Toxicology of Contact Hypersensitivity, 4, 10.3109/9780203482742

Kimber I, 1998, T Lymphocyte Subpopulations in Immunotoxicology, 199

10.1016/S0167-5699(97)01186-9

Basketter D A, 1999, Toxicology of Contact Dermatitis. Allergy, Irritancy and Urticaria

Rustemeyer T, 2001, Textbook of Contact Dermatitis, 14

Smith C K, 2001, Allergic Contact Dermatitis. Chemical and Metabolic Mechanisms

10.1034/j.1600-0536.2002.460101.x

10.1016/0041-008X(92)90230-P

Kimber I, 1999, Dendritic Cells. Biology and Clinical Applications, 295

10.1016/S0952-7915(98)80078-2

10.1046/j.1365-2133.2000.03349.x

10.1046/j.1365-2230.2000.00678.x

10.1016/0278-6915(91)90167-6

10.1016/0278-6915(92)90153-C

10.1016/0300-483X(94)90193-7

Kimber I, 1996, Dermatotoxicology, 469

10.1002/(SICI)1099-1263(199909/10)19:5<299::AID-JAT591>3.0.CO;2-C

Gerberick G F, 1999, Contact sensitization hazard identification, Comments Toxicol, 7, 31

10.1016/S1046-199X(00)90027-7

10.1034/j.1398-9995.2001.00147.x

10.1016/S0165-6147(00)01704-1

10.1016/S0278-6915(01)00130-2

10.1016/0278-6915(86)90124-9

10.1007/BF00278640

10.1111/j.1600-0536.1989.tb03198.x

10.1007/978-3-642-74299-6_115

10.1016/0272-0590(92)90183-I

Hilton J, 1995, Methods in Molecular Biology, 227

Kimber I, 1998, Dermatotoxicology Methods: the Laboratory Worker's Vade Mecum, 145

10.1111/j.1600-0536.1996.tb02353.x

10.1016/0300-483X(93)90148-L

10.1006/faat.1996.0139

10.1016/0300-483X(96)03304-5

10.1111/j.1600-0536.1999.tb06181.x

10.1016/S0278-6915(00)00169-1

10.1046/j.1467-2494.2001.00066.x

10.1016/S0300-483X(02)00131-2

10.1002/(SICI)1099-1263(199807/08)18:4<281::AID-JAT506>3.0.CO;2-4

10.1034/j.1600-0536.2001.044006357.x

10.1016/S0278-6915(99)00112-X

10.3109/15376519509049116

10.1016/S0378-4274(00)00315-5

10.1016/S0300-483X(00)00152-9

10.1093/toxsci/66.2.226

10.1016/0300-483X(94)02957-V

10.1006/taap.1998.8535

10.1007/BF01974070

10.1016/0278-6915(94)90148-1

10.1002/(SICI)1099-1263(199607)16:4<349::AID-JAT351>3.0.CO;2-5

10.1016/S0300-483X(97)00156-X

10.1007/s002040000192

10.1016/S0300-483X(00)00165-7

10.1016/S0300-483X(01)00425-5

10.1016/0278-6915(95)00089-5

10.1016/1056-8719(96)00028-7

10.1016/0300-483X(92)90196-L

10.1016/S0300-483X(96)89846-5

10.1016/0300-483X(91)90232-P

10.1016/0378-4274(91)90135-S

10.3109/15376519109036523

10.1002/jat.2550120312

10.1016/0300-483X(95)03114-U

10.1016/S0278-6915(96)00059-2

10.1016/0300-483X(95)03279-O

10.1080/009841098159141

10.1002/jat.2550100306

10.1016/0278-6915(92)90138-B

10.1111/j.1600-0536.1992.tb03247.x

10.1016/0278-6915(93)90181-W

10.1016/0278-6915(94)90112-0

10.1034/j.1600-0536.2000.043002095.x

10.1006/faat.1994.1096

10.1006/faat.1994.1142

10.1111/j.1600-0536.1991.tb01823.x

10.1016/S1046-199X(98)90142-7

10.1111/j.1600-0536.1999.tb06013.x

10.1016/S1046-199X(99)90070-2

10.1002/(SICI)1099-1263(199609)16:5<459::AID-JAT366>3.0.CO;2-H

10.2307/3431573

10.1016/S0300-483X(01)00380-8

10.1016/S0278-6915(96)00058-0

National Institutes of Health (NIH).The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. NIH no. 99–4494 1999.

10.1006/rtph.2001.1497

10.1006/rtph.2001.1498

10.1006/rtph.2001.1496

Balls M, 2000, Statement on the validity of the local lymph node assay for skin sensitisation testing. ECVAM Joint Research Centre, European Commission, Ispra, ATLA, 28, 366

10.1111/j.1600-0536.1990.tb05166.x

10.1001/archderm.1965.01600080079017

10.1111/j.1600-0536.1981.tb04060.x

Montelius J, 1994, Experience with the murine local lymph node assay: inability to discriminate between allergens and irritants, Acta Dermatol Venereol, 74, 22, 10.2340/00015555744550

10.1016/S0278-6915(97)00158-0

Friedmann P, 1990, The immunology of allergic contact dermatitis: the DNCB story, Adv Dermatol, 5, 175

Andersen K E, 1995, The guinea pig maximization test – with a multiple dose design, Acta Dermatol Venereol, 75, 463, 10.2340/0001555575463469

10.1111/j.1600-0536.1994.tb01921.x

10.1016/S0300-483X(97)00181-9

10.1080/10807039709383695

10.1093/toxsci/59.2.198

10.1016/S0278-6915(99)00048-4

10.1002/(SICI)1099-1263(199907/08)19:4<261::AID-JAT572>3.0.CO;2-5

10.1002/(SICI)1099-1263(199907/08)19:4<255::AID-JAT573>3.0.CO;2-S

10.1034/j.1600-0536.2001.045002089.x

10.1111/j.1600-0536.1997.tb00421.x

10.1034/j.1600-0536.2000.042006344.x

10.1053/ajcd.2001.23926

10.1016/S1046-199X(99)90071-4

10.1016/0278-6915(89)90036-7

10.1097/01634989-199312000-00001

10.1046/j.1467-2494.1998.171746.x

10.1053/AC.2000.3191

Basketter D A, 1999, Chemical allergy: estimation of potency, thresholds and risk assessments, Comments Toxicol, 7, 79

10.1034/j.1600-0536.2000.042005251.x

10.1034/j.1600-0536.2001.450603.x

10.1016/S0278-6915(02)00116-3

10.1006/faat.1996.0172

10.1006/taap.1999.8734

10.1006/taap.1997.8218

10.1093/toxsci/48.2.206

10.1093/toxsci/68.2.420

10.3109/15376519309068444

10.1002/jat.2550140408

Dearman R J, 1994, In Vitro Skin Toxicology, 367

10.1002/(SICI)1099-1263(199905/06)19:3<149::AID-JAT557>3.0.CO;2-L

10.1016/S0278-6915(98)00102-1

10.1093/toxsci/54.2.277

Orphanides G, 2001, Toxicogenomics: theoretical and practical considerations, Comments Toxicol, 7, 333

10.1016/S0887-2333(02)00007-3

10.1016/S0300-483X(02)00598-X

Thông tin
Thông tin xuất bản

Contact Dermatitis

Tập 47 Số 6

315-328

Thông tin tác giả